Llwytho...
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Schizophr Res Cogn |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824953/ https://ncbi.nlm.nih.gov/pubmed/27069875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scog.2016.02.001 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|